March/April 2021

An increasing number of stakeholders rely on health economics and outcomes research (HEOR) evidence to assess relative value, to weigh treatment choices, and to help them target possible patient outcomes under finite budgets. Clinicians, payers, patients, governments, health ministries, and other stakeholders need access to up-to-date HEOR information to inform their understanding of the therapeutic and economic value of a given product in a real-world clinical practice environment and to help clarify their decision making.
VOL. 7, NO. 3

March/April 2021

Navigating the Changing HEOR Publishing Landscape
Vol. 7 | No. 1 - Supplement

March 2021

Valuing Future Alzheimer's Disease Treatments: The Need for a Holistic Approach
VOL. 7, NO. 1

January/February 2021

Overcoming Vaccine Hesitancy: Injecting Trust in the Community
VOL. 6, NO. 6

November/December 2020

Challenges in Precision Medicine: Aiming to Align Data, Value, and Costs
VOL. 6 NO. 6 S2

November 2020 Supplement

November 2020 Supplement: Spotlight on Europe
Vol. 6 No. 5

September/October 2020

Unlocking the Promise of Real-World Evidence
VOL. 6 NO. 5 S1

September 2020 Supplement

September 2020 Supplement: Spotlight on Asia Pacific
VOL. 6 NO. 4

July/August 2020

Behavioral Economics: Examining Human Reactions To COVID-19
VOL. 6 , NO. 3

May/June 2020

Shared Risks, Shared Benefits: Innovative Pricing in Healthcare
VOL. 6 NO. 2

March/April 2020

COVID-19: A Global Crisis
VOL. 6 NO. 1

January/February 2020

The Digital Healthcare Ecosystem: Looking Outside to Harness From Within
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now